Relationship Between Antithrombin III, Antiplasmin and Plasma Lipids in a Healthy Population

• References

• 1 Editorial. Haemostatic factors and coronary heart diseases. Lancet 1981; 01: 22-23
• 2 Meade TW, Chakrabarti R, Haines AP, North WR S, Stirling Y, Thompson SG, Brozovic M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; 01: 1050-1054
• 3 Korsan-Bengtsen K, Wilhelmsen L, Tibblin G. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old: II. Relations of the variables to “risk factors” for myocardial infarction. Thrombos Diathes Haemorrh 1972; 28: 99-108
• 4 Baker IA, Eastham R, Elwood PC, Etherington M, O’Brien JR, Sweetnam PM. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J 1982; 47: 490-494
• 5 Smith EB, Staples EM. Haemostatic factors in human aortic intima. Lancet 1981; 01: 1171-1174
• 6 Lowe GD O, Stromberg P, Forbes CD, McArdle BM, Lorimer AR, Prentice CR M. Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia. Lancet 1982; 1: 472-475
• 7 Winter JH, Bennett B, McTaggart F, Douglas AS. Lipoprotein fractions and antithrombin III consumption during clotting. Thromb Haemostas 1982; 47: 236-238